Vorinostat Combined with Third Generation Tkis to Overcome Egfr C797 Mutation in Lung Adenocarcinoma (I)

2019-08-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/697357表皮生長因子受體(EGFR)抗藥性C797S點突變聯合治療VorinostatEGFRresistanceC797Scombination therapyVorinostatVorinostat Combined with Third Generation Tkis to Overcome Egfr C797 Mutation in Lung Adenocarcinoma (I)